CPSF6-RARγ interacts with histone deacetylase 3 to promote myeloid transformation in RARG-fusion acute myeloid leukemia
Abstract Acute myeloid leukemia (AML) with retinoic acid receptor gamma (RARG) fusions, which exhibits clinical features resembling acute promyelocytic leukemia (APL), has been identified as a new subtype with poor clinical outcomes. The underlying mechanism of RARG-fusion leukemia remains poorly un...
Saved in:
Main Authors: | Tianhui Liu, Tanzhen Wang, Lijuan Qi, Yujie Liu, Meng Shan, Fuqiang Wang, Yanglan Fang, Sining Liu, Lijun Wen, Suning Chen, Depei Wu, Yang Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-54860-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oncogenic role of RARG rearrangements in acute myeloid leukemia resembling acute promyelocytic leukemia
by: Feng Wang, et al.
Published: (2025-01-01) -
Acetylation and Histone Deacetylase Inhibitors in Cancer
by: Madeleine S. Q. Kortenhorst, et al.
Published: (2006-01-01) -
Inhibition of histone deacetylase in Arabidopsis root calli promotes de novo shoot organogenesis
by: Qinwei Pan, et al.
Published: (2025-01-01) -
Histone Deacetylase Inhibitors in Cell Pluripotency, Differentiation, and Reprogramming
by: Androniki Kretsovali, et al.
Published: (2012-01-01) -
Comparison of Different Histone Deacetylase Inhibitors in Attenuating Inflammatory Pain in Rats
by: Yu Mao, et al.
Published: (2019-01-01)